Lipid Screening in Children: Low-Value Care

JAMA Intern Med. 2016 Oct 1;176(10):1437-1438. doi: 10.1001/jamainternmed.2016.5114.

Authors

Thomas B Newman¹, Alan R Schroeder², Mark J Pletcher³

Affiliations

¹ Department of Pediatrics, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California, San Francisco.
² Department of Pediatrics, Stanford University, Stanford, California.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco4Department of Medicine, University of California, San Francisco.

PMID: 27533131
DOI: 10.1001/jamainternmed.2016.5114

No abstract available

Publication types

Editorial

MeSH terms

Adolescent
Adult
Child
Coronary Artery Disease / diagnosis
Coronary Artery Disease / prevention & control
Female
Guidelines as Topic
Humans
Hyperlipoproteinemia Type II / blood
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / economics
Hyperlipoproteinemia Type II / prevention & control*
Life Style
Lipids / blood*
Male
Mass Screening / economics
Risk Factors
United States

Substances

Lipids